Skip to content

Clinical trials

Phase 2 Hepatitis, Alcoholic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Alcoholic Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20132
20143
20161
20171
20181
20191
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Conatus Pharmaceuticals Inc.2
Durect2
Virginia Commonwealth University2
Aldeyra Therapeutics, Inc.1
Craig James McClain1
Gilead Sciences1
Indiana University1
Intercept Pharmaceuticals1
Loma Linda University1
Naga P. Chalasani1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Alcoholic16
Hepatitis3
Fibrosis2
Alcoholism1
Jaundice1
Liver Cirrhosis1
Liver Cirrhosis, Alcoholic1
Liver Diseases1
Liver Diseases, Alcoholic1
Liver Failure1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.